Emergent BioSolutions: FDA to Review AV7909 Anthrax Vaccine Candidate
Emergent BioSolutions: FDA to Review AV7909 Anthrax Vaccine Candidate...…
Börse:
30,985€
9,10%
Echtzeit-Aktienkurs Emergent Biosolutions Inc.
Bid:
30,720€
Ask:
31,250€
Nachrichten zur Emergent Biosolutions Inc. Aktie
Emergent BioSolutions says FDA has accepted its anthrax vaccine candidate for review
Emergent BioSolutions Inc. said Friday the U.S. Food and Drug Administration has accepted for review its application for approval…
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food…
Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious Diseases
GAITHERSBURG, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that two-year persistence data…
J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement
Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent…
Form 8-K Emergent BioSolutions For: Jun 06
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J Plans to End Covid-19 Vaccine Deal With Emergent BioSolutions
Johnson & Johnson said it planned to terminate the deal with contract manufacturer Emergent BioSolutions, as both companies accused each…
J&J to end COVID vaccine manufacturing deal with Emergent Biosolutions
Johnson & Johnson said Monday it planned to terminate its COVID-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each…
Emergent BioSolutions Says Janssen Has Breached Covid Vaccine Contract
Emergent BioSolutions Says Janssen Has Breached Covid Vaccine Contract...…
Emergent BioSolutions to Participate in Investor Conferences
GAITHERSBURG, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of…
Form 8-K Emergent BioSolutions For: May 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Opening Bell: Apple, JP Morgan, EA, VMWare, Emergent BioSolutions, Xpeng, Foot Locker, Oatly, HP
Vor dem Wochenende legte der Dow Jones einen imposanten Schlussspurt hin. Er ging nahezu unverändert aus dem Handel. Zwischenzeitlich notierte…
Pre-market Movers: SIGA, VMW, EVTL, TNXP, Emergent BioSolutions.
BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Mondays pre-market trading (as of 06.45…
Thinking about buying stock in Rivian Automotive, Siyata Mobile, Emergent Biosolutions, Stryve Foods, or IQIYI?
NEW YORK, May 20, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RIVN, SYTA, EBS, SNAX, and IQ. To…
Implied Volatility Surging for Emergent Biosolutions (EBS) Stock Options
Investors need to pay close attention to Emergent Biosolutions (EBS) stock based on the movements in the options market lately....…
Monkeypox Case Reported in U.S. Emergent BioSolutions Makes a Vaccine.
The ACAM2000 vaccine can be used to prevent the spread of monkeypox, according to the CDC....…
Form 8-K Emergent BioSolutions For: May 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Chimerix stock surges after deal to sell smallpox treatment Tembexa for up to $337.5 million, plus royalties
Shares of Chimerix Inc. shot up 14.4% in premarket trading Monday, after the biopharmaceutical company said it will sell…
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has…
Chimerix to sell smallpox treatment Tembexa to Emergent BioSolutions for $337.5 mln plus royalties
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
– $225 Million in Upfront Proceeds Secures Substantial Capital to Fund Operations and Allows for Participation in Future Economics –...…
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 26, 2022 at 9:00am EDT
GAITHERSBURG, Md., May 12, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2022…
Contract vaccine maker Emergent Biosolutions accused of cover-up by House panel
Executives at contract vaccine manufacturer Emergent BioSolutions covered up quality control problems that led to more than 400 million doses…
SHAREHOLDER ALERT: Weiss Law Investigates Emergent BioSolutions Inc.
NEW YORK, May 10, 2022 /PRNewswire/ -- Weiss Law, a national shareholders rights law firm, is investigating possible false claims,…
House panel alleges cover-up by contract vaccine maker
WASHINGTON (AP) — Executives at contract vaccine manufacturer Emergent BioSolutions covered up quality control problems that led to more than…
BRIEF-Emergent BioSolutions Hid Evidence Of Quality Control Problems From FDA In Feb 2021 - NYT
...May 10 (Reuters) -
* EMERGENT HID EVIDENCE OF QUALITY CONTROL......…
Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of…
Emergent BioSolutions (EBS) Q1 2022 Earnings Call Transcript
EBS earnings call for the period ending March 31, 2022....…
Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements
read more...…
Emergent BioSolutions dips on lowered price target at Cowen amid lowering Narcan revenue guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Emergent BioSolutions Stock Is Sinking Today
The companys Q1 results were disappointing....…
Form 10-Q Emergent BioSolutions For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Emergent BioSolutions For: Apr 28
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions to Release First Quarter 2022 Financial Results and Conduct Conference Call on April 28, 2022
GAITHERSBURG, Md., April 08, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call…
Emergent Biosolutions to Eliminate Executive Chairman Role as Founder Retires >EBS
Emergent Biosolutions to Eliminate Executive Chairman Role as Founder Retires >EBS...…
Form 8-K Emergent BioSolutions For: Mar 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions names Zsolt Harsanyi as chairman
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions Provides Corporate Governance Update
GAITHERSBURG, Md., March 23, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its board…
Emergent BioSolutions to Participate in Investor Conferences
GAITHERSBURG, Md., March 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of…
Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning
GAITHERSBURG, Md., March 11, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has…
Form 10-K Emergent BioSolutions For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions Inc. 2021 Q4 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions Stock Fell Today -- Is It a Buy?
Theres considerable uncertainty about the companys near-term prospects....…
Emergent BioSolutions (EBS) Q4 2021 Earnings Call Transcript
EBS earnings call for the period ending December 31, 2021....…
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2021 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Emergent BioSolutions For: Feb 24
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Emergent BioSolutions For: Feb 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions: Still A Bargain Regardless Of Diminished Growth Forecasts
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022
GAITHERSBURG, Md., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call…
Emergent BioSolutions rises on upgrade by Benchmark
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…